Foxsemicon (3168): Shareholders Approve Waiver of Non-Compete Restrictions for Directors and Representatives
Foxsemicon has obtained shareholder approval to waive non-compete restrictions for directors and representatives serving concurrent roles within the group.
📋 Article Processing Timeline
- 📰 Published: May 21, 2026 at 06:31
- 🔍 Collected: May 21, 2026 at 06:31 (0 min after Published)
- 🤖 AI Analyzed: May 21, 2026 at 06:36 (4 min after Collected)
Report Date: May 21, 115
Announcement Date: May 20, 115
Time: 17:55:08
Ticker: 3168
Company: Foxsemicon
Subject: Announcement regarding the approval of the non-compete waiver for directors and their representatives at the 115 Annual General Meeting.
1. Date of Shareholders' Meeting: 115/05/20
2. Directors and Titles Permitted to Engage in Competitive Activities:
(1) Corporate Director: Qisda Corp.
(2) Corporate Director Representative (Qisda Corp.): Hsueh, Dao-Lung
(3) Corporate Director Representative (Qisda Corp.): Hung, Chiu-Chin
(4) Independent Director: Yeh, Hui-Hsin
(5) Independent Director: Chu, Hsuan-Lien
3. Permitted Competitive Activities:
Includes serving as Chairpersons or Directors in numerous Qisda Group affiliated companies, such as BenQ Materials Corp., Alpha Networks Inc., and Daxon Technology Inc.
4. Duration of Permission: During the tenure as a director or representative of Foxsemicon.
5. Voting Results: Approved by a majority attendance of outstanding shares and a two-thirds majority of voting rights present.
6. Mainland China Business Involvements:
Representative: Hung, Chiu-Chin (Corporate Director, Qisda Corp.)
Companies involved include entities such as Shanghai Felt Technology, Nanjing BenQ Hospital, and Suzhou BenQ Hospital, focusing on medical device sales and hospital management consulting.
Announcement Date: May 20, 115
Time: 17:55:08
Ticker: 3168
Company: Foxsemicon
Subject: Announcement regarding the approval of the non-compete waiver for directors and their representatives at the 115 Annual General Meeting.
1. Date of Shareholders' Meeting: 115/05/20
2. Directors and Titles Permitted to Engage in Competitive Activities:
(1) Corporate Director: Qisda Corp.
(2) Corporate Director Representative (Qisda Corp.): Hsueh, Dao-Lung
(3) Corporate Director Representative (Qisda Corp.): Hung, Chiu-Chin
(4) Independent Director: Yeh, Hui-Hsin
(5) Independent Director: Chu, Hsuan-Lien
3. Permitted Competitive Activities:
Includes serving as Chairpersons or Directors in numerous Qisda Group affiliated companies, such as BenQ Materials Corp., Alpha Networks Inc., and Daxon Technology Inc.
4. Duration of Permission: During the tenure as a director or representative of Foxsemicon.
5. Voting Results: Approved by a majority attendance of outstanding shares and a two-thirds majority of voting rights present.
6. Mainland China Business Involvements:
Representative: Hung, Chiu-Chin (Corporate Director, Qisda Corp.)
Companies involved include entities such as Shanghai Felt Technology, Nanjing BenQ Hospital, and Suzhou BenQ Hospital, focusing on medical device sales and hospital management consulting.
FAQ
Why is the non-compete waiver for directors necessary?
It is a legal procedure to allow directors to serve in concurrent roles at group companies, facilitating cooperation and efficient management.
How is this proposal approved?
It requires attendance of shareholders representing a majority of the outstanding shares and the approval of two-thirds of the voting rights present at the shareholders meeting.
What are the non-compete items for mainland China operations?
These refer to positions held in companies engaged in medical device sales or management consulting in Shanghai and Suzhou.